ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,297,209 | -73.1% | 10,900 | -59.7% | 0.00% | – |
| Q2 2023 | $4,818,792 | +40.3% | 27,043 | +29.9% | 0.00% | – |
| Q1 2023 | $3,434,302 | -76.4% | 20,819 | -77.4% | 0.00% | -100.0% |
| Q4 2022 | $14,535,876 | +311.7% | 92,303 | +293.7% | 0.00% | – |
| Q3 2022 | $3,531,000 | +100.7% | 23,446 | +196.8% | 0.00% | – |
| Q1 2022 | $1,759,000 | -92.4% | 7,900 | -91.9% | 0.00% | – |
| Q4 2021 | $23,096,000 | +17.7% | 97,304 | +15.7% | 0.00% | -100.0% |
| Q3 2021 | $19,623,000 | +516.9% | 84,085 | +444.1% | 0.00% | – |
| Q2 2021 | $3,181,000 | +22.7% | 15,455 | +22.5% | 0.00% | – |
| Q1 2021 | $2,593,000 | -73.7% | 12,618 | -72.6% | 0.00% | -100.0% |
| Q4 2020 | $9,866,000 | +106.8% | 46,000 | +76.2% | 0.00% | 0.0% |
| Q3 2020 | $4,770,000 | -47.8% | 26,100 | -47.4% | 0.00% | -50.0% |
| Q2 2020 | $9,142,000 | -42.1% | 49,600 | -36.7% | 0.00% | -60.0% |
| Q1 2020 | $15,799,000 | +212.8% | 78,300 | +190.1% | 0.01% | +400.0% |
| Q4 2019 | $5,051,000 | -55.6% | 26,991 | -62.1% | 0.00% | -75.0% |
| Q3 2019 | $11,364,000 | -81.1% | 71,200 | -70.2% | 0.00% | -42.9% |
| Q2 2019 | $60,173,000 | +181.2% | 238,862 | +167.2% | 0.01% | -22.2% |
| Q1 2019 | $21,396,000 | +133.5% | 89,400 | +124.0% | 0.01% | +125.0% |
| Q4 2018 | $9,163,000 | -74.9% | 39,904 | -69.1% | 0.00% | -66.7% |
| Q3 2018 | $36,544,000 | +26.1% | 129,244 | +30.9% | 0.01% | +20.0% |
| Q2 2018 | $28,983,000 | +321.1% | 98,701 | +262.0% | 0.01% | +400.0% |
| Q1 2018 | $6,882,000 | -50.7% | 27,267 | -57.8% | 0.00% | -50.0% |
| Q4 2017 | $13,965,000 | +333.0% | 64,655 | +272.5% | 0.00% | +300.0% |
| Q3 2017 | $3,225,000 | -12.6% | 17,355 | -18.8% | 0.00% | 0.0% |
| Q2 2017 | $3,690,000 | +20.3% | 21,386 | +6.4% | 0.00% | -50.0% |
| Q1 2017 | $3,068,000 | -46.8% | 20,092 | -48.7% | 0.00% | 0.0% |
| Q4 2016 | $5,771,000 | +290.2% | 39,171 | +234.8% | 0.00% | – |
| Q3 2016 | $1,479,000 | +147.3% | 11,700 | +120.8% | 0.00% | – |
| Q2 2016 | $598,000 | -71.3% | 5,300 | -73.5% | 0.00% | -100.0% |
| Q1 2016 | $2,082,000 | -16.3% | 20,000 | -9.4% | 0.00% | +100.0% |
| Q4 2015 | $2,488,000 | -49.1% | 22,068 | -50.6% | 0.00% | -50.0% |
| Q3 2015 | $4,887,000 | -29.7% | 44,635 | -38.6% | 0.00% | -33.3% |
| Q2 2015 | $6,954,000 | +346.9% | 72,696 | +335.3% | 0.00% | +200.0% |
| Q1 2015 | $1,556,000 | +108.3% | 16,700 | +83.0% | 0.00% | – |
| Q4 2014 | $747,000 | -14.4% | 9,127 | -32.9% | 0.00% | – |
| Q3 2014 | $873,000 | +9.1% | 13,605 | +3.3% | 0.00% | – |
| Q2 2014 | $800,000 | -23.2% | 13,170 | -24.3% | 0.00% | – |
| Q1 2014 | $1,042,000 | -40.9% | 17,400 | -37.1% | 0.00% | -100.0% |
| Q4 2013 | $1,762,000 | -38.0% | 27,664 | -33.9% | 0.00% | 0.0% |
| Q3 2013 | $2,843,000 | +266.4% | 41,862 | +289.2% | 0.00% | – |
| Q2 2013 | $776,000 | – | 10,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |